Search Results 71-80 of 17396 for celiac disease.
A Study to Evaluate the Safety, Effectiveness, and Tolerability of Latiglutenase to Treat Patients with Well-Controlled Celiac Disease · Share · Facebook · Twitter.
A Study to Evaluate the Effectiveness and Safety of PRV-015 in Adult Patients wth Non-responsive Celiac Disease as an Adjunct to a Gluten-free Diet.
The purpose of this study is to assess the safety and tolerable of single and multiple doses of KAN-101 in patients with Celiac disease. Participation ...
Liver diseases. These include scarring of the liver called cirrhosis and chronic hepatitis B and C infections. Celiac disease. Eating gluten, a protein ...
... celiac disease (CD) and dermatitis herpetiformis (DH). Other enteropathies ... disease, and other miscellaneous inflammatory disorders of the small intestine.
Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten- ...
Mayo Clinic gastroenterologist Dr. Joseph Murray says only about 1 percent of Americans have celiac disease and should not eat gluten, the.
histicola a "brug — the bug acts like a drug." MS, rheumatoid arthritis and celiac disease are common autoimmune diseases caused when the body's immune system, ...
Excess fat in the stool, such as due to a malabsorption condition, for example, celiac disease. Fatty foods such as deep-fried foods, and sometimes the protein ...
... and symptoms in celiac disease patients. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.